CN1812814A - 用于治疗乳腺炎和耳疾病的可分散的药物组合物 - Google Patents

用于治疗乳腺炎和耳疾病的可分散的药物组合物 Download PDF

Info

Publication number
CN1812814A
CN1812814A CNA2004800183007A CN200480018300A CN1812814A CN 1812814 A CN1812814 A CN 1812814A CN A2004800183007 A CNA2004800183007 A CN A2004800183007A CN 200480018300 A CN200480018300 A CN 200480018300A CN 1812814 A CN1812814 A CN 1812814A
Authority
CN
China
Prior art keywords
compositions
antibacterial
methyl
medicament
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800183007A
Other languages
English (en)
Chinese (zh)
Inventor
N·J·布里滕
N·A·沃尔德伦
J·L·沃茨
J·W·哈尔贝格
J·W·伯恩斯二世
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Pharmacia and Upjohn Co LLC
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CN1812814A publication Critical patent/CN1812814A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
CNA2004800183007A 2003-07-31 2004-07-19 用于治疗乳腺炎和耳疾病的可分散的药物组合物 Pending CN1812814A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49217803P 2003-07-31 2003-07-31
US60/492,178 2003-07-31

Publications (1)

Publication Number Publication Date
CN1812814A true CN1812814A (zh) 2006-08-02

Family

ID=34103028

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800183007A Pending CN1812814A (zh) 2003-07-31 2004-07-19 用于治疗乳腺炎和耳疾病的可分散的药物组合物

Country Status (13)

Country Link
EP (1) EP1656159A2 (es)
JP (1) JP2007500692A (es)
KR (1) KR100807414B1 (es)
CN (1) CN1812814A (es)
AU (1) AU2004258746A1 (es)
BR (1) BRPI0412923A (es)
CA (1) CA2529405A1 (es)
IL (1) IL171893A0 (es)
MX (1) MXPA06001192A (es)
NO (1) NO20055466L (es)
RU (1) RU2329064C2 (es)
WO (1) WO2005009472A2 (es)
ZA (1) ZA200600850B (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104622875A (zh) * 2015-02-12 2015-05-20 江西博莱大药厂有限公司 一种抗奶牛乳腺炎的乳房注入药剂及其制备方法
CN105358131A (zh) * 2013-08-12 2016-02-24 诺华股份有限公司 用于治疗鼓膜造孔插管放置后的耳部感染的方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740214B1 (en) * 2004-04-22 2007-10-03 Pfizer Products Incorporated Method of stabilizing disordered cefovecin sodium salt
NZ702087A (en) * 2012-06-29 2016-12-23 Bayer Animal Health Gmbh Pharmaceutical compositions and treatment of mastitis
PL3370698T3 (pl) * 2015-11-03 2022-04-25 Zoetis Services Llc Kompozyty polimerowe zol-żel i ich zastosowania
RU2663070C1 (ru) * 2017-05-04 2018-08-01 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ лечения отомикоза

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9701731A (es) * 1995-06-06 1997-10-31 Bayer Ag Composiciones anti-bacterianas oticas, no-irritantes, no-sensibles y no-toxicas para el oido.
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105358131A (zh) * 2013-08-12 2016-02-24 诺华股份有限公司 用于治疗鼓膜造孔插管放置后的耳部感染的方法
CN104622875A (zh) * 2015-02-12 2015-05-20 江西博莱大药厂有限公司 一种抗奶牛乳腺炎的乳房注入药剂及其制备方法
CN104622875B (zh) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 一种抗奶牛乳腺炎的乳房注入药剂及其制备方法

Also Published As

Publication number Publication date
NO20055466D0 (no) 2005-11-18
WO2005009472A2 (en) 2005-02-03
BRPI0412923A (pt) 2006-09-26
KR20060033031A (ko) 2006-04-18
MXPA06001192A (es) 2006-04-11
ZA200600850B (en) 2007-05-30
KR100807414B1 (ko) 2008-02-25
CA2529405A1 (en) 2005-02-03
EP1656159A2 (en) 2006-05-17
AU2004258746A1 (en) 2005-02-03
RU2329064C2 (ru) 2008-07-20
WO2005009472A3 (en) 2005-04-07
IL171893A0 (en) 2006-04-10
JP2007500692A (ja) 2007-01-18
RU2006102665A (ru) 2006-06-10
NO20055466L (no) 2006-04-21

Similar Documents

Publication Publication Date Title
CN1761486A (zh) 用于治疗乳腺炎及耳部疾病的可分散药物组合物
TWI262084B (en) Dispersible formulation of an anti-inflammatory agent
CN1829510A (zh) 抗炎剂的可分散性制剂
CN1720065A (zh) 可分散的药物组合物
US20080153894A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US20050009931A1 (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
CN1812814A (zh) 用于治疗乳腺炎和耳疾病的可分散的药物组合物
US20050004098A1 (en) Dispersible formulation of an anti-inflammatory agent
US20040033938A1 (en) Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1089373

Country of ref document: HK

AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1089373

Country of ref document: HK